Active	Status	Sponsor type	Region	Phase	Filter
7 Active 3 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Xia, Bing
TQB2450-III-05, NCT04325763: A Study of TQB2450 in Subjects With Stage III Non-Small Cell Lung Cancer(NSCLC)	Recruiting	3	315	RoW	TQB2450, Anlotinib, TQB2450(blank), Anlotinib(blank)	Chia Tai Tianqing Pharmaceutical Group Co., Ltd.	Stage III Non-small-cell Lung Cancer	12/22	03/25
NCT06536400: Phase I Study of HSK42360 in Solid Tumors With BRAF V600 Mutation	Recruiting	1	316	RoW	HSK42360	Haisco Pharmaceutical Group Co., Ltd.	Solid Tumors	08/26	07/27
Oliveira, Laurie De
No trials found